Home / Resource Library / Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma

Article discusses modified lymphodepletion to improve outcomes in patients with DLBCL receiving CAR-T.